Portfolio and Licensing Services

Optimize portfolio performance and business strategy with sound industry intelligence, expert analysis and perspective.

Pharmaceutical companies rely on a fully informed business development strategy to secure competitive advantage.

  • Making balanced portfolio decisions in a complex and rapidly changing competitive environment.
  • Identification of innovative science that can feed a dwindling, early stage pipeline.
  • Reliance on deal making drives customers to seek high value assets and formulate a competitive BD&L strategy.
  • Accurate prediction of clinical progression and product launches require vigilant monitoring of competitor pipelines that are constantly shifting.
  • Competitive advantage is gained by acquisition of insight from subject matter experts across R&D, Commercial, Marketing, and Clinical space.
  • Repositioning existing pipeline drugs to rapidly enter a new therapeutic space and diversify a narrow portfolio.
  • Increasing focus on emerging markets creates demand for competitive intelligence in China, India, Latin America and elsewhere.

The Clarivate Analytics  professional services team provides comprehensive services that deliver a view of the competitive landscape, holistic commercial view for indication selection, and accelerated evaluation of deal structures and asset values.

9,000

Our consultants have worked on 9,000 drug programs around the world

> 100

> 100 customers globally

19

19 out of top 20 pharmaceutical  companies

500

All Fortune Global 500 pharmaceutical companies

Jamie Munro

Jamie Munro

Director, Portfolio and Licensing Professional Services

Find out more

Speak to our team

Want to learn more about Professional Services?

Contact us